15-22094536-C-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM1BP4_Strong
The NM_001005241.4(OR4N4):c.15C>A(p.Asn5Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.0 ( 0 hom., cov: 0)
Exomes 𝑓: 0.00017 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
OR4N4
NM_001005241.4 missense
NM_001005241.4 missense
Scores
2
3
14
Clinical Significance
Conservation
PhyloP100: -1.51
Genes affected
OR4N4 (HGNC:15375): (olfactory receptor family 4 subfamily N member 4) Olfactory receptors interact with odorant molecules in the nose, to initiate a neuronal response that triggers the perception of a smell. The olfactory receptor proteins are members of a large family of G-protein-coupled receptors (GPCR) arising from single coding-exon genes. Olfactory receptors share a 7-transmembrane domain structure with many neurotransmitter and hormone receptors and are responsible for the recognition and G protein-mediated transduction of odorant signals. The olfactory receptor gene family is the largest in the genome. The nomenclature assigned to the olfactory receptor genes and proteins for this organism is independent of other organisms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM1
In a glycosylation_site N-linked (GlcNAc...) asparagine (size 0) in uniprot entity OR4N4_HUMAN
BP4
Computational evidence support a benign effect (MetaRNN=0.057366997).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4N4 | NM_001005241.4 | c.15C>A | p.Asn5Lys | missense_variant | 1/1 | ENST00000328795.6 | |
OR4M2-OT1 | NR_110480.1 | n.847C>A | non_coding_transcript_exon_variant | 8/9 | |||
OR4M2-OT1 | NR_110481.1 | n.579C>A | non_coding_transcript_exon_variant | 6/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4N4 | ENST00000328795.6 | c.15C>A | p.Asn5Lys | missense_variant | 1/1 | NM_001005241.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 0AN: 50Hom.: 0 Cov.: 0 FAILED QC
GnomAD3 genomes
AF:
AC:
0
AN:
50
Hom.:
Cov.:
0
FAILED QC
Gnomad AFR
AF:
Gnomad AMR
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000153 AC: 35AN: 228810Hom.: 2 AF XY: 0.000130 AC XY: 16AN XY: 123060
GnomAD3 exomes
AF:
AC:
35
AN:
228810
Hom.:
AF XY:
AC XY:
16
AN XY:
123060
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000170 AC: 4AN: 23574Hom.: 0 Cov.: 0 AF XY: 0.0000822 AC XY: 1AN XY: 12166
GnomAD4 exome
AF:
AC:
4
AN:
23574
Hom.:
Cov.:
0
AF XY:
AC XY:
1
AN XY:
12166
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AC0;AS_VQSR AF: 0.00 AC: 0AN: 50Hom.: 0 Cov.: 0 AF XY: 0.00 AC XY: 0AN XY: 22
GnomAD4 genome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
AC:
0
AN:
50
Hom.:
Cov.:
0
AF XY:
AC XY:
0
AN XY:
22
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ExAC
AF:
AC:
19
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2023 | The c.15C>A (p.N5K) alteration is located in exon 1 (coding exon 1) of the OR4N4 gene. This alteration results from a C to A substitution at nucleotide position 15, causing the asparagine (N) at amino acid position 5 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Pathogenic
.;M
MutationTaster
Benign
N
PrimateAI
Benign
T
PROVEAN
Pathogenic
.;D
REVEL
Benign
Sift
Uncertain
.;D
Sift4G
Uncertain
.;D
Polyphen
0.98
.;D
Vest4
0.33
MutPred
Gain of methylation at N5 (P = 0.001);Gain of methylation at N5 (P = 0.001);
MVP
0.40
MPC
0.30
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at